Clinical Trials Directory

Trials / Completed

CompletedNCT00248989

Effect of DHEA on Skin Aging in Postmenopausal Women

Effect of DHEA on Skin Aging - Placebo-Controlled and Randomized Phase III Study in Postmenopausal Women.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
150 (actual)
Sponsor
CHU de Quebec-Universite Laval · Academic / Other
Sex
Female
Age
60 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine the response of skin parameters related to skin aging to the local action of DHEA in postmenopausal women.

Detailed description

Humans, along with the others primates, are unique among animal species in having adrenals that secrete large amounts of the inactive precursor steroids dehydroepiandrosterone(DHEA)and especially its sulfate DHEA-S. The marked reduction in the formation of DHEA-S by the adrenals during aging results in a dramatic fall in the formation of androgens and estrogens in peripheral target tissues, a situation that has been proposed to be associated with age-related diseases including skin atrophy, insulin resistance and obesity. Moreover, much attention has been given to the benefits of DHEA administered to postmenopausal women, especially on the bone, skin, vagina and well being after oral as well as percutaneous administration of the precursor steroid. Therefore this study proposes to study the effect of 0.3% DHEA cream during a period of 12 months administered twice daily to postmenopausal women. During the study several biological and clinical parameters will be evaluated. In summary, these include blood steroid levels, distribution of hormonal receptors in the skin, sebaceous gland activity, skin hydration, skin wrinkles and finally skin genomic evaluation. Subjects will be evaluated at specific time intervals for the above mentioned parameters as well as tolerability and adverse reactions.

Conditions

Interventions

TypeNameDescription
DRUGDehydroepiandrosterone3.0 ml of 0.3% DHEA cream applied on the skin twice daily.
DRUGPlacebos3.0 ml of placebo cream applied on the skin twice daily.

Timeline

Start date
2004-11-01
Primary completion
2005-11-24
Completion
2008-11-13
First posted
2005-11-04
Last updated
2017-04-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00248989. Inclusion in this directory is not an endorsement.